COMPARISON OF INNATE IMMUNITY CHANGES FOLLOWING IBRUTINIB AND VENETOCLAX TREATMENT OF RELAPSED CHRONIC LYMPHOCYTIC LEUKAEMIA. (June 2017) - Mason, K.; Sharpe, C.; Davis, J.; Koldej, R.; Tam, C.; Ritchie, D.